skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Jared Wolff, Zach McLellan, Jack Allen, and Maha Elsayed discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast.

 

Special thanks to Kevin (Kayj) Shannon for joining us on the podcast this week! Kayj is a cardiovascular and metabolic diseases analyst for Datamonitor Healthcare who is based in San Diego, CA.

 

Topics covered in our second episode include:

Epidiolex’s role as a cannabinoid treatment for pediatric epilepsy (0:36)
Puma Biotechnology's niratinib upcoming advisory committee meeting (7:15)
CRL issued to Eli Lilly and Incyte for baricitinib in rheumatoid arthritis (14:27)
Discussion of key second quarter market catalysts for Radius Health, Intercept Pharmaceuticals, FibroGen, and Cara Therapeutics (23:21)

 

Click hear to listen 

 

 

To learn more about Datamonitor Healthcare and our offerings, vist: https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/datamonitor-healthcare

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: